viewNaturally Splendid Enterprises Ltd.

Naturally Splendid provides data after receiving Health Canada Information request

Naturally Splendid (CVE: NSP- OTCPINK: NSPDF) CEO Craig Goodwin joined Steve Darling from Proactive to share news the company has responded to Health Canada's Information Request Notice. The IRN was designed to determine the final dosage of Cavaltinib intended for use as a COVID treatment and to define the final criteria for the selection of patients making up the test and control groups for the trial.

Goodwin talks about this step in the process and of they have been given any timelines from Health Canada.

Quick facts: Naturally Splendid Enterprises Ltd.

Price: 0.05 CAD

Market: TSX-V
Market Cap: $10.09 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Naturally Splendid Enterprises Ltd. named herein, including the promotion by the Company of Naturally Splendid Enterprises Ltd. in any Content...



Quadrise Fuels International completes industrial pilot for alternative fuel...

Quadrise Fuels International PLC's (LON:QFI) Mike Kirk and Jason Miles talk to Proactive's London's Katie Pilbeam about the completion of their alternative fuel trial, MSAR, at an international chemical group customer’s plant in Morocco. Kirk explains the potential and opportunities for their...

3 hours, 53 minutes ago

2 min read